| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049532A1 Cgrp receptor antagonists |
| 04/22/2009 | EP2049531A2 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 04/22/2009 | EP2049530A2 Crystalline nemorubicin hydrochloride |
| 04/22/2009 | EP2049529A1 Substituted diazepan orexin receptor antagonists |
| 04/22/2009 | EP2049528A2 Fungicide n-cycloalkyl-carboxamide derivatives |
| 04/22/2009 | EP2049517A1 Amino-piperidine derivatives as cetp inhibitors |
| 04/22/2009 | EP2049514A1 Nitrate esters of piperidines |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049484A1 Isoindoline derivatives for the treatment of arrhythmias |
| 04/22/2009 | EP2049168A2 Coating of artificial surfaces of medical aids and instruments, and cleaning and/or pretreatment of catheters and other medical aids and instruments |
| 04/22/2009 | EP2049120A1 Urotensin ii receptor antagonists |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | EP1628972B1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 04/22/2009 | EP1585518A4 Peptide deformylase inhibitors |
| 04/22/2009 | EP1528925B1 Quinazoline derivatives for use in the treatment of cancer |
| 04/22/2009 | EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 04/22/2009 | CN101415703A Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/22/2009 | CN101415702A Hetero compound |
| 04/22/2009 | CN101415701A Heterocyclylacrylamide compounds as FABI inhibitors and antibacterial agents |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101415681A Pyridine and pyrimidine derivatives as mGluR2 antagonists |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN101412711A Carbamate derivatives and use thereof in medicine |
| 04/22/2009 | CN101412709A Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480389C Production of polyketides |
| 04/22/2009 | CN100480245C 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/21/2009 | US7521563 Hydroxamic acid derivative and medicine containing the same as active ingredient |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521449 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7521004 Chromene compound |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/16/2009 | WO2009049305A2 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 04/16/2009 | WO2009048750A2 Insecticidal (1,3,5)-triazinyl phenyl hydrazones |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | WO2009047797A2 Process for the preparation of perhydroisoindole derivative |
| 04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2009046536A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 04/16/2009 | WO2008108380A3 Pyrrole compounds |
| 04/16/2009 | WO2008032072A8 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 04/16/2009 | WO2008015693A3 Process for the preparation of mycophenolate mofetil |
| 04/16/2009 | WO2008011453A3 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 |
| 04/16/2009 | WO2006104917A3 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099356 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction |
| 04/16/2009 | US20090099244 Organic compounds |
| 04/16/2009 | US20090099243 Organic compounds |
| 04/16/2009 | US20090099232 Injectable depot formulation comprising crystals of iloperidone |
| 04/16/2009 | US20090099209 Compounds Useful in Therapy |
| 04/16/2009 | US20090099207 Cyclic sulfones useful as BACE inhibitors |
| 04/16/2009 | US20090099201 Diacylglycerol Acyltransferase Inhibitors |
| 04/16/2009 | US20090099199 Organic compounds |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099184 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099182 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/16/2009 | US20090099180 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/16/2009 | US20090099178 Indazole compounds and methods of use thereof |
| 04/16/2009 | US20090099177 Pyridyl compounds |
| 04/16/2009 | US20090099176 Pyrrolopyridine-2-carboxylic acid amides |
| 04/16/2009 | US20090099175 Phosphodiesterase 10 inhibitors |
| 04/16/2009 | US20090099171 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 04/16/2009 | US20090099170 Sirtuin modulating compounds |
| 04/16/2009 | US20090099169 Benzofuran Compounds As EP1 Receptor Antagonists |
| 04/16/2009 | US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors |
| 04/16/2009 | US20090099158 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor |
| 04/16/2009 | US20090099156 Heterocyclic Compounds as Ccr2b antagonists |
| 04/16/2009 | US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090098410 Trimethine Dimer Compound and Optical Recording Medium Using the Same |
| 04/16/2009 | US20090098189 Azaindoles as inhibitors of soluble adenylate cyclase |
| 04/16/2009 | CA2702225A1 Diphenyl substituted cycloalkanes |
| 04/16/2009 | CA2702171A1 Amide compound |
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
| 04/16/2009 | CA2700893A1 Substituted tetrazole compounds and uses thereof |
| 04/16/2009 | CA2700049A1 Novel compounds as cannabinoid receptor ligands |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2046774A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 04/15/2009 | EP2046769A2 Aldh-2 inhibitors in the treatment of addiction |
| 04/15/2009 | EP2046765A1 Insecticidal compounds |
| 04/15/2009 | EP2046764A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 04/15/2009 | EP2046762A2 Triazolyl phenyl benzenesulfonamides |
| 04/15/2009 | EP2046761A2 Macrocyclic compounds useful as bace inhibitors |
| 04/15/2009 | EP2046758A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/15/2009 | EP2046757A1 Caspase inhibitors based on pyridazinone scaffold |
| 04/15/2009 | EP1725235B1 Piperidine derivatives useful as ccr3 antagonists |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |